Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
I-MAB has a consensus price target of $12.25 based on the ratings of 4 analysts. The high is $25 issued by Cantor Fitzgerald on September 5, 2023. The low is $6 issued by Needham on April 12, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on November 15, 2024, September 17, 2024, and August 29, 2024, respectively. With an average price target of $8 between HC Wainwright & Co., there's an implied 709.72% upside for I-MAB from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for I-MAB (NASDAQ:IMAB) was reported by HC Wainwright & Co. on November 15, 2024. The analyst firm set a price target for $8.00 expecting IMAB to rise to within 12 months (a possible 709.72% upside). 8 analyst firms have reported ratings in the last year.
The latest analyst rating for I-MAB (NASDAQ:IMAB) was provided by HC Wainwright & Co., and I-MAB reiterated their buy rating.
There is no last upgrade for I-MAB
There is no last downgrade for I-MAB.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of I-MAB, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for I-MAB was filed on November 15, 2024 so you should expect the next rating to be made available sometime around November 15, 2025.
While ratings are subjective and will change, the latest I-MAB (IMAB) rating was a reiterated with a price target of $8.00 to $8.00. The current price I-MAB (IMAB) is trading at is $0.99, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.